Encompass Health (AMEX:EHC) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Wednesday, January 10th.
According to Zacks, “HealthSouth Corporation is dedicated to comprehensive rehabilitation medicine. In the hospital and at home, HealthSouth’s team of experts is focused solely on rehabilitation. They collaborate closely on decisions, goals and therapy options. Their priority is to deliver high quality patient care and their team of experts has extensive experience in today’s most advanced therapeutic methods and technologies. HealthSouth leads the way, intensive approach to rehabilitation, returning patients to full strength in less than average time. HealthSouth has the most advanced technology, a highly qualified rehabilitation team and unparalleled depth of experience. Therapy is performed to get the patient back to the highest level of strength and function after illness, injury or surgery. The focus is completely on the patient and family, doing what’s right for recovery in a positive atmosphere of encouragement, support and respect for individual needs. “
Several other research firms have also issued reports on EHC. Royal Bank of Canada restated a “buy” rating on shares of Encompass Health in a research report on Wednesday, November 15th. Mizuho raised shares of Encompass Health from a “neutral” rating to a “buy” rating and set a $55.00 target price for the company in a research note on Thursday, November 2nd. William Blair reiterated an “outperform” rating on shares of Encompass Health in a research report on Tuesday, November 21st. Piper Jaffray Companies reiterated a “hold” rating and set a $50.00 price target on shares of Encompass Health in a research report on Sunday, September 17th. Finally, SunTrust Banks set a $58.00 price objective on shares of Encompass Health and gave the company a “buy” rating in a report on Thursday, December 21st. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating and nine have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $54.55.
Shares of Encompass Health (AMEX EHC) traded down $0.54 during trading hours on Wednesday, hitting $52.43. 65,367 shares of the company traded hands, compared to its average volume of 546,962. Encompass Health has a fifty-two week low of $38.97 and a fifty-two week high of $54.13. The company has a current ratio of 1.34, a quick ratio of 1.34 and a debt-to-equity ratio of 1.89. The stock has a market cap of $5,150.00, a P/E ratio of 19.14, a PEG ratio of 1.70 and a beta of 0.49.
Several hedge funds have recently bought and sold shares of the company. Copeland Capital Management LLC bought a new position in Encompass Health in the 4th quarter valued at approximately $28,117,000. Dalton Greiner Hartman Maher & Co. bought a new position in Encompass Health in the 4th quarter valued at approximately $16,395,000. Horrell Capital Management Inc. bought a new position in Encompass Health during the 4th quarter worth approximately $1,415,000. Nisa Investment Advisors LLC bought a new position in Encompass Health during the 4th quarter worth approximately $1,157,000. Finally, Jensen Investment Management Inc. bought a new position in Encompass Health during the 4th quarter worth approximately $756,000. 93.18% of the stock is owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY WARNING: “Zacks Investment Research Upgrades Encompass Health (EHC) to Hold” was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this article on another domain, it was illegally copied and republished in violation of U.S. & international copyright laws. The legal version of this article can be accessed at https://www.dispatchtribunal.com/2018/02/02/encompass-health-ehc-lifted-to-hold-at-zacks-investment-research.html.
About Encompass Health
Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.
Get a free copy of the Zacks research report on Encompass Health (EHC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.